These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 32804464)
21. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Eskenazi A; Lood C; Wubbolts J; Hites M; Balarjishvili N; Leshkasheli L; Askilashvili L; Kvachadze L; van Noort V; Wagemans J; Jayankura M; Chanishvili N; de Boer M; Nibbering P; Kutateladze M; Lavigne R; Merabishvili M; Pirnay JP Nat Commun; 2022 Jan; 13(1):302. PubMed ID: 35042848 [TBL] [Abstract][Full Text] [Related]
22. Successful treatment of ventriculitis caused by Gofman N; To K; Whitman M; Garcia-Morales E Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534 [TBL] [Abstract][Full Text] [Related]
23. A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam. Iacovelli A; Spaziante M; Al Moghazi S; Giordano A; Ceccarelli G; Venditti M Infection; 2018 Oct; 46(5):721-724. PubMed ID: 29926399 [TBL] [Abstract][Full Text] [Related]
26. Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Athans V; Neuner EA; Hassouna H; Richter SS; Keller G; Castanheira M; Brizendine KD; Mathers AJ Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30578403 [TBL] [Abstract][Full Text] [Related]
27. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in Giddins MJ; Macesic N; Annavajhala MK; Stump S; Khan S; McConville TH; Mehta M; Gomez-Simmonds A; Uhlemann AC Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263067 [TBL] [Abstract][Full Text] [Related]
28. Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization. Gaibani P; Re MC; Campoli C; Viale PL; Ambretti S Clin Microbiol Infect; 2020 Apr; 26(4):516.e1-516.e4. PubMed ID: 31740422 [TBL] [Abstract][Full Text] [Related]
29. Changes in KPC-producing Boattini M; Bianco G; Comini S; Iannaccone M; Casale R; Charrier L; Cavallo R; Costa C Infect Dis (Lond); 2022 Apr; 54(4):311-313. PubMed ID: 34871146 [No Abstract] [Full Text] [Related]
30. In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections. Stone GG; Bradford PA; Yates K; Newell P J Antimicrob Chemother; 2017 May; 72(5):1396-1399. PubMed ID: 28088768 [TBL] [Abstract][Full Text] [Related]
32. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae in Greece: A single-centre study. Protonotariou E; Meletis G; Kachrimanidou M; Papadopoulou D; Stamou A; Arhonti M; Skoura L J Glob Antimicrob Resist; 2020 Mar; 20():82-83. PubMed ID: 31821890 [No Abstract] [Full Text] [Related]
34. Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City. Manning N; Balabanian G; Rose M; Landman D; Quale J Microb Drug Resist; 2018; 24(1):35-39. PubMed ID: 28590820 [TBL] [Abstract][Full Text] [Related]
35. Successful rescue treatment of sepsis due to a pandrug-resistant, NDM-producing Klebsiella pneumoniae using aztreonam powder for nebulizer solution as intravenous therapy in combination with ceftazidime/avibactam. Sieswerda E; van den Brand M; van den Berg RB; Sträter J; Schouls L; van Dijk K; Budding AE J Antimicrob Chemother; 2020 Mar; 75(3):773-775. PubMed ID: 31789378 [No Abstract] [Full Text] [Related]
36. Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime-avibactam. Cani E; Moussavi F; Ocheretyaner E; Sharma R; Brown C; Eilertson B Transpl Infect Dis; 2018 Apr; 20(2):e12837. PubMed ID: 29359842 [TBL] [Abstract][Full Text] [Related]
37. KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues. Antonelli A; Giani T; Di Pilato V; Riccobono E; Perriello G; Mencacci A; Rossolini GM J Antimicrob Chemother; 2019 Aug; 74(8):2464-2466. PubMed ID: 31318973 [No Abstract] [Full Text] [Related]
38. Efficacy of ceftazidime-avibactam in a rat intra-abdominal abscess model against a ceftazidime- and meropenem-resistant isolate of Klebsiella pneumoniae carrying bla Sleger T; Gangl E; Pop-Damkov P; Krause KM; Laud PJ; Slee AM; Nichols WW J Chemother; 2018 Apr; 30(2):95-100. PubMed ID: 29191131 [TBL] [Abstract][Full Text] [Related]
39. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252 [TBL] [Abstract][Full Text] [Related]
40. Ceftazidine-avibactam salvage therapy in newborn with KPC-producing Klebsiella pneumoniae invasive infections. Esposito P; Sbrana F; Di Toro A; Gombos S; Tascini C Minerva Anestesiol; 2019 Jul; 85(7):804-805. PubMed ID: 31271023 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]